MENU
BPMC
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION
Blueprint Medicines (BPMC) Ownership - Who owns Blueprint Medicines?
Industry: @Biotechnology
Profile
Industry
Biotechnology
Address
45 Sidney Street
Phone
+1 617 374-7580
Employees
655
Web
https://www.blueprintmedicines.com
Details
Group
Domestic Stock Funds
Category
Biotechnology
Capitalization
6.08B
P/E Ratio
N/A
Total Cash
734.17M
Projected Growth
N/A
Total Debt
471.5M
Revenue
434.42M
Risk (Beta)
0.97
Dividend Yield
N/A
Total Cash/Share
11.56
Total Debt/Equity
N/A
Revenue/Share
6.99 USD as % of share price
Fundamentals
BPMC
Capitalization
6.08B
P/E Ratio
N/A
Risk (Beta)
0.97
Dividend Yield
N/A
Total Cash
734M
Total Cash/Share
11.56
Total Debt
471M
Total Debt/Equity
N/A
Projected Growth (PEG Ratio)
N/A
Revenue/Share (as % of the share price)
6.99%
Revenue
434M
ROE
N/A
Book Value
313M
P/B Ratio
19.42
Cash Flow
N/A
Earnings
-2.09
Average Daily Volume YTD
N/A
Common Shares Outstanding - Security Level
63K
Current Ratio
3.32
Current Revenue Per Employee
195700.77
Dividends Per Share - Security
N/A
EBITDA
-75.58M
Float
N/A
Float - Current
N/A
Gross Income Margin
98.49
Revenue To Assets
-11.11
Shares Held By Institutions
15.5B
Shares Outstanding - Current
63.5M
Total Liabilities
887M
Total Volume MTD
N/A
Value
-1
Gain YTD
5.030
View a ticker or compare two or three
VS
VS
Show more...
Ad is loading...
A.I.Advisor
published price charts
A.I. Advisor
published General Information
General Information
a developer of cancer therapies that harness the growing understanding of the molecular blueprint of cancer
Industry Biotechnology
Profile
Fundamentals
Details
Industry
Biotechnology
Address
45 Sidney Street
Phone
+1 617 374-7580
Employees
655
Web
https://www.blueprintmedicines.com